2Horn LC,Schnurrbusch U,Bilek K,et al.Risk of progression in complex and atypical endometrial hyperplasia:clinicopathologic analysis in caese with and without peogestogen treatment[J].Int J Gynecol Cancer,2004,14(2):348-353.
4Vereide AB,Arnes M,Staume B,et al.Nuclear morphometeic changes and therapy monitoring in patients with endometrial hyperplasia:a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone[J].Gynecol Oncol,2003,91(3):526-533.
5Figueroa-Casas PR,Ettinger B,Delgado E,et al.Reversal by medical treatment of endometrial hyperplasia caused by estrogen replacement therapy[J].Menopasuse,2001,8(6):420-423.
6Perez Medina T,Bajo,J,Folgueira G,et al.Atypiacl endometrial hyperplasia treatment with progestogens and gonadotropin releasing hormone analogues:long term follow up[J].Gynecol Oncol,1997,73:299-304.
7Grimbiziis G,Tsalikis T,Tzioufa V,et al.Regressin of endometrial hyperplasia after treatment with the gonaditrophin relesin hormone analofue triptorelin:a prospective study[J].Hum Reprod,1999,14(2):479-484.
8Niwa K,Hashimoto M,Morishita S,et al.Preventive effects of danazol on endometrial[J].Cancer Lett,2000,158(2):133-139.
9Fraser IS.Treatment of dysfunctional uteine bleeding with danazol[J].Aust N Z J Obstet Gynaecol,1985,25(3):224-226
